Gold Nanoparticle-Assisted Virus Formation by Means of the Delivery of an Oncolytic Adenovirus Genome
Luis Sendra,
Antonio Miguel,
M. Carmen Navarro-Plaza,
María José Herrero,
José de la Higuera,
Consuelo Cháfer-Pericás,
Elena Aznar,
M. Dolores Marcos,
Ramón Martínez-Máñez,
Luis Alfonso Rojas,
Ramón Alemany,
Salvador F. Aliño
Affiliations
Luis Sendra
Gene Therapy Group, Department of Pharmacology, Faculty of Medicine, Universitat de València, Av Blasco Ibáñez 15, 46010 València, Spain
Antonio Miguel
Gene Therapy Group, Department of Pharmacology, Faculty of Medicine, Universitat de València, Av Blasco Ibáñez 15, 46010 València, Spain
M. Carmen Navarro-Plaza
Gene Therapy Group, Department of Pharmacology, Faculty of Medicine, Universitat de València, Av Blasco Ibáñez 15, 46010 València, Spain
María José Herrero
Gene Therapy Group, Department of Pharmacology, Faculty of Medicine, Universitat de València, Av Blasco Ibáñez 15, 46010 València, Spain
José de la Higuera
Gene Therapy Group, Department of Pharmacology, Faculty of Medicine, Universitat de València, Av Blasco Ibáñez 15, 46010 València, Spain
Consuelo Cháfer-Pericás
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València, Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain
Elena Aznar
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València, Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain
M. Dolores Marcos
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València, Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain
Ramón Martínez-Máñez
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València, Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain
Luis Alfonso Rojas
Catalan Institute of Oncology–IDIBELL, Av Gran Via 199-203, 08908 Barcelona, L’Hospitalet de Llobregat, Spain
Ramón Alemany
Catalan Institute of Oncology–IDIBELL, Av Gran Via 199-203, 08908 Barcelona, L’Hospitalet de Llobregat, Spain
Salvador F. Aliño
Gene Therapy Group, Department of Pharmacology, Faculty of Medicine, Universitat de València, Av Blasco Ibáñez 15, 46010 València, Spain
Oncolytic adenoviruses are a therapeutic alternative to treat cancer based on their ability to replicate selectively in tumor cells. However, their use is limited mainly by the neutralizing antibody (Nab) immune response that prevents repeated dosing. An alternative to facilitate the DNA access to the tumor even in the presence of anti-viral Nabs could be gold nanoparticles able to transfer DNA molecules. However, the ability of these nanoparticles to carry large DNA molecules, such as an oncolytic adenovirus genome, has not been studied. In this work, gold nanoparticles were functionalized with different amounts of polyethylenimine to transfer in a safe and efficient manner a large oncolytic virus genome. Their transfer efficacy and final effect of the oncolytic virus in cancer cells are studied. For each synthesized nanoparticle, (a) DNA loading capacity, (b) complex size, (c) DNA protection ability, (d) transfection efficacy and (e) cytotoxic effect were studied. We observed that small gold nanoparticles (70–80 nm in diameter) protected DNA against nucleases and were able to transfect the ICOVIR-15 oncolytic virus genome encoded in pLR1 plasmid. In the present work, efficient transgene RNA expression, luciferase activity and viral cytopathic effect on cancer cells are reported. These results suggest gold nanoparticles to be an efficient and safe vector for oncolytic adenovirus genome transfer.